Cheng‐Long Han

582 total citations
39 papers, 351 citations indexed

About

Cheng‐Long Han is a scholar working on Oncology, Hepatology and Molecular Biology. According to data from OpenAlex, Cheng‐Long Han has authored 39 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Hepatology and 9 papers in Molecular Biology. Recurrent topics in Cheng‐Long Han's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Cheng‐Long Han is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Liver Disease Diagnosis and Treatment (7 papers). Cheng‐Long Han collaborates with scholars based in China, United States and United Kingdom. Cheng‐Long Han's co-authors include Tao Li, Zhao‐Ru Dong, Zi‐Niu Ding, Bao‐Wen Tian, Lun‐Jie Yan, Dongxu Wang, Hui Liu, Jun-Shuai Xue, Jian‐Guo Hong and Zhiqiang Chen and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Environmental Pollution and Frontiers in Immunology.

In The Last Decade

Cheng‐Long Han

35 papers receiving 343 citations

Peers

Cheng‐Long Han
Tianying Zheng China
Elisabeth S. Gruber Austria
Weijun Wang China
Guodong Chen China
Shiyin Wei China
Paul Brennan France
Yuhui He China
Jianzheng Wang China
Liqun Chen China
Tianying Zheng China
Cheng‐Long Han
Citations per year, relative to Cheng‐Long Han Cheng‐Long Han (= 1×) peers Tianying Zheng

Countries citing papers authored by Cheng‐Long Han

Since Specialization
Citations

This map shows the geographic impact of Cheng‐Long Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Long Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Long Han more than expected).

Fields of papers citing papers by Cheng‐Long Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Long Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Long Han. The network helps show where Cheng‐Long Han may publish in the future.

Co-authorship network of co-authors of Cheng‐Long Han

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Long Han. A scholar is included among the top collaborators of Cheng‐Long Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Long Han. Cheng‐Long Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hui, Lun‐Jie Yan, Zi‐Niu Ding, et al.. (2025). An umbrella review of the association between dietary factors and hepatocellular carcinoma risk. Food & Function. 16(10). 3879–3890.
2.
Yan, Zhibo, Cheng‐Long Han, Jun Jia, et al.. (2025). The landscape of gut microbiota in hepatocarcinogenesis: a comprehensive review of pathogenesis and therapeutic interventions. International Journal of Surgery. 112(1). 1673–1695.
3.
Liu, Shijia, Xiao Zhang, Lun‐Jie Yan, et al.. (2025). Comparison of tenofovir versus entecavir for preventing hepatocellular carcinoma in chronic hepatitis B patients: an umbrella review and meta-analysis. Journal of Cancer Research and Clinical Oncology. 151(2). 77–77.
4.
Jia, Ziqi, Heng Cao, Jiayi Li, et al.. (2025). Advanced strategy for cancer detection based on volatile organic compounds in breath. Journal of Nanobiotechnology. 23(1). 468–468. 2 indexed citations
5.
6.
Curtis, Jeffrey R., Atul Deodhar, Enrique R. Soriano, et al.. (2024). Early Improvements with Guselkumab Associate with Sustained Control of Psoriatic Arthritis: Post hoc Analyses of Two Phase 3 Trials. Rheumatology and Therapy. 11(6). 1501–1517. 2 indexed citations
7.
Liu, Hui, Lun‐Jie Yan, Zi‐Niu Ding, et al.. (2024). Role of hepatitis B core‐related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta‐analysis. Journal of Gastroenterology and Hepatology. 39(8). 1464–1475. 2 indexed citations
8.
Xu, Mengyao, et al.. (2023). Chattonella marina blooms in a trophic gradient system: Interaction with environmental drivers. Marine Pollution Bulletin. 199. 115958–115958.
9.
Yu, Xue, Bing Wang, Cheng‐Long Han, et al.. (2023). Physicochemical and biological changes on naturally aged microplastic surfaces in real environments over 10 months. Environmental Pollution. 337. 122522–122522. 18 indexed citations
10.
11.
Ma, Yunlong, Chuncheng Yang, Lun‐Jie Yan, et al.. (2023). A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response. Frontiers in Pharmacology. 14. 1101749–1101749. 7 indexed citations
12.
Tian, Bao‐Wen, Cheng‐Long Han, Lun‐Jie Yan, et al.. (2023). Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis. Clinical & Experimental Metastasis. 40(4). 255–287. 7 indexed citations
13.
Shi, Shuo, Lun‐Jie Yan, Zi‐Niu Ding, et al.. (2023). A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients. Biomarker Research. 11(1). 87–87. 11 indexed citations
14.
15.
Han, Cheng‐Long, Zi‐Niu Ding, Zhao‐Ru Dong, et al.. (2022). The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis. Frontiers in Immunology. 13. 827788–827788. 27 indexed citations
16.
Tian, Bao‐Wen, Lun‐Jie Yan, Zi‐Niu Ding, et al.. (2022). Evaluating liver function and the impact of immune checkpoint inhibitors in the prognosis of hepatocellular carcinoma patients: A systemic review and meta-analysis. International Immunopharmacology. 114. 109519–109519. 4 indexed citations
17.
Ye, Li, Yi Qing, Xiaoli Liao, et al.. (2021). Hypomethylation-driven overexpression of HJURP promotes progression of hepatocellular carcinoma and is associated with poor prognosis. Biochemical and Biophysical Research Communications. 566. 67–74. 15 indexed citations
18.
19.
Tian, Xiao‐Yun, Xinliang Zhang, Cheng‐Long Han, et al.. (2015). Observation on the effect of preoperative radiotherapy on the local advanced middle and low rectal cancer. 27(12). 810–813. 1 indexed citations
20.
Han, Cheng‐Long, Jie Shen, Hao Wang, et al.. (2012). Personalized primary tumor xenograft model established for the pre-clinical trial to guide postoperative chemotherapy. Medical Hypotheses. 79(6). 705–708. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tianying Zheng Breakdown of academic impact, for papers by Elisabeth S. Gruber Breakdown of academic impact, for papers by Weijun Wang Breakdown of academic impact, for papers by Guodong Chen Breakdown of academic impact, for papers by Shiyin Wei Breakdown of academic impact, for papers by Paul Brennan Breakdown of academic impact, for papers by Yuhui He Breakdown of academic impact, for papers by Jianzheng Wang Breakdown of academic impact, for papers by Liqun Chen
Rankless by CCL
2026